Search Within

Sucharita Adluri

Formats
  1. Journal Article (18)
  2. Meeting Abstract (7)
Groups
  1. Department of Medicine (16)
  2. Solid Tumor Oncology Division (16)
  3. Melanoma and Immunotherapeutics Service (15)
  4. Melanoma Disease Management Team (14)
  5. Sloan Kettering Institute Faculty (6)
  6. Behavioral Sciences Service (5)

More Groups

People
  1. Philip Livingston (25)
  2. Govindaswami Ragupathi (14)
  3. Shengle Zhang (12)
  4. Kenneth Lloyd (9)
  5. Friedhelm Helling (7)
  6. Herbert Oettgen (5)

More People

Years
  1. 2000 (2)
  2. 1999 (4)
  3. 1997 (6)
  4. 1996 (3)
  5. 1995 (4)
  6. 1994 (4)

More Years

Publications
  1. Proceedings of the American Association for Cancer Research Annual Meeting (6)
  2. International Journal of Cancer (4)
  3. Cancer Research (3)
  4. Angewandte Chemie - International Edition (2)
  5. Cancer Immunology, Immunotherapy (2)
  6. Vaccine Research (2)

More Publications

Publishers
  1. American Association for Cancer Research (10)
  2. John Wiley & Sons (4)
  3. Springer (3)
  4. Mary Ann Liebert, Inc. (2)
  5. Wiley Blackwell (2)
  6. American Society of Clinical Oncology (1)

More Publishers

Results (25)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tumor cell reactivity mediated by IgM antibodies in sera from melanoma patients vaccinated with GM2 ganglioside covalently linked to KLH is increased by IgG antibodies
    Journal Article

    Livingston, P.; Zhang, S.; Adluri, S.; Yao, T. J.; Graeber, L.; Ragupathi, G.; Helling, F.; Fleisher, M.
    Cancer Immunology, Immunotherapy (1997)

    Fulltext@MSK | Save
  • Immunization of mice with a fully synthetic globo H antigen results in antibodies against human cancer cells: A combined chemical-immunological approach to the fashioning of an anticancer vaccine
    Journal Article

    Ragupathi, G.; Park, T. K.; Zhang, S.; Kim, I. J.; Graber, L.; Adluri, S.; Lloyd, K. O.; Danishefsky, S. J.; Livingston, P. O.
    Angewandte Chemie - International Edition (1997)

    Fulltext@MSK | Save
  • Approaches to augmenting the immunogenicity of synthetic MUC1 peptide in mice
    Meeting Abstract

    Zhang, S.; Graeber, L.; Helling, F.; Ragupathi, G.; Adluri, S.; Lloyd, K. O.; Livingston, P. O.
    Proceedings of the American Association for Cancer Research Annual Meeting (1996)

    Fulltext@MSK | Save
  • Immunization of mice with the synthetic hexasaccharide Globo H results in antibodies against human breast cancer cells
    Meeting Abstract

    Ragupathi, G.; Zhang, S.; Park, T. K.; Kim, I. J.; Graeber, L.; Adluri, S.; Lloyd, K. O.; Danishefsky, S. J.; Livingston, P. O.
    Proceedings of the American Association for Cancer Research Annual Meeting (1996)

    Fulltext@MSK | Save
  • Augmenting the immunogenicity of synthetic MUC1 peptide vaccines in mice
    Journal Article

    Zhang, S.; Graeber, L. A.; Helling, F.; Ragupathi, G.; Adluri, S.; Lloyd, K. O.; Livingston, P. O.
    Cancer Research (1996)

    Fulltext@MSK | Save
  • Impact of immunological adjuvants and administration route on HAMA response after immunization with murine monoclonal antibody MELIMMUNE-1 in melanoma patients
    Journal Article

    Livingston, P. O.; Adluri, S.; Zhang, S.; Chapman, P.; Raychaudhuri, S.; Merritt, J. A.
    Vaccine Research (1995)

    Fulltext@MSK | Save
  • Analysis of the antibody response to immunization with purified O‐acetyl GD3 gangliosides in patients with malignant melanoma
    Journal Article

    Ritter, G.; Ritter‐Boosfeld, E.; Adluri, R.; Calves, M.; Ren, S.; Yu, R. K.; Oettgen, H. F.; Old, L. J.; Livingston, P. O.
    International Journal of Cancer (1995)

    Fulltext@MSK | Save
  • G(M2)-KLH conjugate vaccine: Increased immunogenicity in melanoma patients after administration with immunological adjuvant QS-21
    Journal Article

    Helling, F.; Zhang, S.; Shang, A.; Adluri, S.; Calves, M.; Koganty, R.; Longenecker, B. M.; Yao, T. J.; Oettgen, H. F.; Livingston, P. O.
    Cancer Research (1995)

    Fulltext@MSK | Save
  • Immunogenicity of synthetic TF-KLH (keyhole limpet hemocyanin) and sTn-KLH conjugates in colorectal carcinoma patients
    Journal Article

    Adluri, S.; Helling, F.; Ogata, S.; Zhang, S.; Itzkowitz, S. H.; Lloyd, K. O.; Livingston, P. O.
    Cancer Immunology, Immunotherapy (1995)

    Fulltext@MSK | Save
  • Phase I trial immunological adjuvant QS-21 with a GM2 ganglioside-KLH conjugate vaccine in patients with malignant melanoma
    Meeting Abstract

    Helling, F.; Livingston, P. O.; Adluri, S.; Shang, A.; Yao, T. J.; Kensil, C. R.; Newman, M. J.; Marciani, D.
    Proceedings of the American Association for Cancer Research Annual Meeting (1994)

    Fulltext@MSK | Save